[1] ICH. ICH E11(R1): Addendum: Clinical Investigation of Medicinal Products in the Pediatric Population[EB/OL].(2017-08-18)[2022-01-06]. https://database.Ich.Org/sites/default/files/E11_R1_Addendum.pdf. [2] ZHANG M, XIAO HL.FDA requirements for pediatric information in human prescription drug and biological product labeling[J]. Drug Evaluation Research, 2020, 43(7): 1228-1232. [3] Nation Medical Products Administration. National Adverse Drug Reaction Annual Test Report (2014)[EB/OL].(2015-07-17)[2022-01-06]. https://www.nmpa.gov.cn/xxgk/yjjsh/ypblfytb/20150717150401333.html. [4] Nation Medical Products Administration. National Adverse Drug Reaction Annual Test Report (2016)[EB/OL].(2017-04-28)[2022-01-06]. https://www.nmpa.gov.cn/directory/web/nmpa/xxgk/fgwj/gzwj/gzwjyp/20170428132601249.html. [5] Nation Medical Products Administration. National Adverse Drug Reaction Annual Test Report (2017)[EB/OL].(2018-04-10)[2022-01-06]. https://www.nmpa.gov.cn/yaopin/ypggtg/ypqtgg/20180413171401472.html. [6] WANG M.A case of neonatal respiratory and circulatory failure caused by overdose of Yinzhihuang injection and review of litera-ture[J]. Journal of Pediatric Pharmacy, 2011, 17(3): 63-64. [7] CHEN YH, KUANG JX.Care of 2 cases of allergic reactions caused by intravenous infu-sion of fishy grass[J]. Contemporary Nurse, 2006(8): 95-96. [8] LIU CH, WU SZ. Luxin Jing(颅囟经)[M]. Beijing: China Medical Science Press, 2020. [9] QIAN Y.Key to Therapeutics of Children's Diseases(小儿药证直决)[M]. Beijing: People's Medical Publishing House, 2017. [10] LIU F.A New Book of Pediatrics(幼幼新书)[M]. Beijing: China Medical Science Press, 2017. [11] ZENG SR.Huo You Xin Shu(活幼心书)[M]. Beijing: People's Medical Publishing House, 2006. [12] WANG Q.You Ke Fa Hui(幼科发挥)[M]. Beijing: People's Medical Publishing House, 2006. [13] CHEN FZ.Collection of Words on Pediatrics.(幼幼集成)[M]. Beijing: People's Medical Publishing House, 2006. [14] SHEN JA.You Ke Shi Mi(幼科释迷)[M]. Beijing: People's Military Medical Publishing House, 2012. [15] ZHANG B, LIN ZJ, ZHANG XM.Pharmacovigilance of Chinese medi-cine: practice of cognition, application, prevention and rescue of drug toxicity[J]. China Journal of Chinese Materia Medica, 2017, 42(10): 2017-2020. [16] WANG S, HUANG SZ, CHEN SH.Retrospective analysis of 308 cases of pediatric adverse drug reactions[J]. Journal of Pediatric Pharmacy, 2021, 27(1): 49-52. [17] ZHAO XH, HAN ZH, LIU H.Outpatient oral chinese patent medicine prescriptions in a grade Ⅲ Level A hospital in 2017[J]. Journal of Pediatric Pharmacy, 2019, 25(3): 47-49. [18] SHEN YX, LIU ZG, LI SW, et al.Investigation of off-label drug use in pediatric outpatient department of our hospital in 2017[J]. Journal of Pediatric Pharmacy, 2020, 26(3): 31-36. [19] ZHANG HL, LI L, ZHAO L, et al.Application status of chinese patent medicine in pediatric emergency of our hospital[J]. Journal of Pediatric Pharmacy, 2021, 27(12): 43-46. [20] HOU JH, WU MY.Exploration of the idea of "maintenance" for children in You Ke Shi Mi[J]. Chinese Medicine Bulletin, 2016, 15(1): 33-35. [21] ZHANG EJ, MENG JH.Thought pattern of properly counseling medication and safely taking drugs during lactation[J]. Herald of Medicine, 2019, 38(10): 1354-1359. [22] WU LL.Adverse drug reactions monitoring and rational drug use intervention in pediatrics[J]. Chinese Community Doctors, 2019, 35(8): 85-86. |